Endothelin ET(B) receptors show different binding profiles in intact cells and cell membrane preparations

European Journal of Pharmacology

Volumn 345, Issue 3, 1998, Pages 339-342

  Hara, Mariko ^a   Tozawa, Fumiyo ^a   Itazaki, Kohji ^a   Mihara, Shin Ichi ^a   Fujimoto, Masafumi ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Endothelin ET(B) receptor; Endothelin 3; Girardi heart cell; Heart neonatal rat

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN B RECEPTOR; L 749329; LIGAND; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CONTROLLED STUDY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANIMALS; ANIMALS, NEWBORN; CELL MEMBRANE; CELLS, CULTURED; ENDOTHELIN-2; HUMANS; IODINE RADIOISOTOPES; LIGANDS; MALE; MYOCARDIUM; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN;

EID: 0032568305     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00016-8     Document Type: Article

References (12)

1. Clozel, M., Gray, G.A., Breu, V., Loffler, B.-M., Osterwalder, R., 1992. The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem. Biophys. Res. Commun. 186, 867-873.
2. Fujimoto, M., Mihara, S., Nakajima, S., Ueda, M., Nakakmura, M., Sakurai, K., 1992. A novel non-peptide endothelin antagonist isolated from bayberry, Myrica cerifera. FEBS Lett. 305, 41-44.
3. Jones, R.L., Miller, J.C., Hagler, H.K., Chien, K.R., Willerson, J.T., Buja, L.M., 1989. Association between inhibition of arachidonic acid release and prevention of calcium loading during ATP depletion in cultured rat cardiac myocytes. Am. J. Pathol. 135, 541-556.
4. Kenakin, T., 1995. Agonist-receptor efficacy II: agonist trafficking of receptor signals. Trends Pharmacol. Sci. 16, 232-238.
5. Mihara, S., Fujimoto, M., 1993. The endothelin ETA receptor-specific effect of 50-235, a nonpeptide endothelin antagonist. Eur. J. Pharmacol. 246, 33-38.
6. Reynolds, E.E., Hwang, O., Flynn, M.A., Welch, K.M., Cody, W.L., Steinbaugh, B., He, J.X., Chung, F.Z., Doherty, A.M., 1995. Pharmacological differences between rat and human endothelin B receptors. Biochem. Biophys. Res. Commun. 209, 506-512.
7. Sakurai, T., Yanagisawa, M., Masaki, T., 1990. Molecular characterization of the endothelin receptors. Trends Pharmacol. Sci. 13, 103-108.
8. B receptors mediating venous smooth muscle contraction. Biochem. Biophys. Res. Commun. 200, 627-633.
9. B receptor-specific antagonist. Biochem. Biophys. Res. Commun. 209, 712-716.
10. Warner, T.D., Allcock, G.H., Mickley, E.J., Corder, R., Vane, J.R., 1993. Comparative studies with endothelin receptor antagonists BQ-123 and PD 142893 indicate at least three endothelin receptors. J. Cardiovasc. Pharmacol. 22, S117-S120, (Suppl 8).
11. Yanagisawa, M., Masaki, T., 1989. Endothelin, a novel endothelium-derived peptide. Pharmacological activities, regulation and possible roles in cardiovascular control. Biochem. Pharmacol. 38, 1877-1883.
12. Yang, H.-T., Zhu, Y., Endoh, M., 1997. Species-dependent differences in inotropic effects and phosphoinositide hydrolysis induced by endothelin-3 in mammalian ventricular myocardium. Br. J. Pharmacol. 120, 1497-1504.